La Direttiva NIS originale (NIS1) è stata lanciata nel 2016 per rafforzare la cybersicurezza nei servizi essenziali. Ma è diventato subito chiaro: non era sufficiente

I prezzi dinamici sono ovunque. Probabilmente li hai visti in azione quando prenoti voli, hotel o anche durante i saldi stagionali. I prezzi cambiano in tempo reale in base alla domanda e all'offerta, alle condizioni di mercato e altro ancora.

Staying ahead of the NIS2 compliance timeline is business-critical for digital health, SaaS, and tech innovators handling sensitive data. The phased deadlines, national differences, and steep penalties mean that proactive, structured action is the safest route to avoid costly setbacks and safeguard your reputation.

The NIS2 Directive is now live. Here’s what to know about the 2025 enforcement, how to check if you're in scope, and what steps to take for compliance—without the overwhelm.

One hot topic lighting up conversations at DMEA this year is C5 certification—a standard that cloud service providers now need to meet to stay compliant. Most people still don’t fully understand what it means, who it applies to, or how expensive it can be.

If your business handles personal data in the EU or, the GDPR is a rulebook you can't afford to ignore. But understanding it is one thing—knowing if you're actually following it is another. That’s where a GDPR compliance audit comes in.

AI is transforming our lives, but in digital health the road to innovation is never smooth. In Germany, many hospitals and health insurers are saying no to cloud-based solutions. Why? Security concerns and a need for strict (even unrealistic) certifications.

Expanding into the U.S. digital health market is an exciting opportunity for European companies. With a market valued at over $300 billion and growing rapidly, the potential is huge. But regulations differ significantly from the EU, meaning companies must adapt to new compliance frameworks before they can succeed.

Digital health entrepreneurs face hard choices early on. They have to develop a compelling product and take it to market. But they also are operating in a highly regulated space. So, they need to also focus at least some attention on data privacy and security. In this market these aren’t a “nice to have”, they’re often a requirement to be able to launch, close your first deal or even do clinical studies.